|
|
||||||||



* Institute of Pharmacology and
Department of Biomorphology School of Medicine, University of Messina, Italy School of Medicine, University of Messina, Italy; G. D Searle,
Discovery Pharmacology, St. Louis, Missouri 63167, USA;
§ Department of Pharmacological and Physiological Sciences, Saint Louis University School of Medicine, St. Louis, Missouri 63104, USA;
|| Metaphore Pharmaceuticals, St. Louis, Missouri 63110, USA
1Correspondence: Institute of Pharmacology, School of Medicine, University of Messina, Torre Biologica, Policlinico Universitario Via C. Valeria-Gazzi, 98100 Messina, Italy. E-mail: salvator{at}www.unime.it
The aim of the present study was to investigate the protective effect of the peroxynitrite decomposition catalyst 5,10,15,20-tetrakis(2,4,6-trimethyl-3,5-disulfonatophenyl)-porphyrinato iron (III) (FeTMPS) in a model of splanchnic artery occlusion shock (SAO). SAO shock was induced in rats by clamping both the superior mesenteric artery and the celiac trunk for 45 min, followed by release of the clamp (reperfusion). At 60 min after reperfusion, animals were killed for histological examination and biochemical studies. There was a marked increase in the oxidation of dihydrorhodamine 123 to rhodamine (a marker of peroxynitrite-induced oxidative processes) in the plasma of the SAO-shocked rats after reperfusion, but not during ischemia alone. Immunohistochemical examination demonstrated a marked increase in the immunoreactivity to nitrotyrosine, an index of nitrogen species such as peroxynitrite, in the necrotic ileum in shocked rats. SAO-shocked rats developed a significant increase of tissue myeloperoxidase and malonaldehyde activity, and marked histological injury to the distal ileum. SAO shock was also associated with a significant mortality (0% survival at 2 h after reperfusion). Reperfused ileum tissue sections from SAO-shocked rats showed positive staining for P-selectin localized mainly in the vascular endothelial cells. Ileum tissue sections obtained from SAO-shocked rats and stained with antibody to ICAM-1 showed a diffuse staining. Administration of FeTMPS significantly reduced ischemia/reperfusion injury in the bowel, and reduced lipid and the production of peroxynitrite during reperfusion. Treatment with PN catalyst also markedly reduced the intensity and degree of P-selectin and ICAM-1 staining in tissue sections from SAO-shocked rats and improved survival. Our results clearly demonstrate that peroxynitrite decomposition catalysts exert a protective effect in SAO and that this effect may be due to inhibition of the expression of adhesion molecules and the tissue damage associated with peroxynitrite-related pathways.Cuzzocrea, S., Misko, T. P., Costantino, C., Mazzon, E., Micali, A., Caputi, A. P., Macarthur, H., Salvemini, D. Beneficial effects of peroxynitrite decomposition catalyst in a rat model of splanchnic artery occlusion and reperfusion.
Key Words: SAO polymorphonuclear leukocyte cytokine nitrate
This article has been cited by other articles:
![]() |
C. I. Jones III, Z. Han, T. Presley, S. Varadharaj, J. L. Zweier, G. Ilangovan, and B. R. Alevriadou Endothelial cell respiration is affected by the oxygen tension during shear exposure: role of mitochondrial peroxynitrite Am J Physiol Cell Physiol, July 1, 2008; 295(1): C180 - C191. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Pacher, J. S. Beckman, and L. Liaudet Nitric Oxide and Peroxynitrite in Health and Disease Physiol Rev, January 1, 2007; 87(1): 315 - 424. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Cuzzocrea, E. Mazzon, R. Di Paola, E. Esposito, H. Macarthur, G. M. Matuschak, and D. Salvemini A Role for Nitric Oxide-Mediated Peroxynitrite Formation in a Model of Endotoxin-Induced Shock J. Pharmacol. Exp. Ther., October 1, 2006; 319(1): 73 - 81. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Tentori, C. Leonetti, M. Scarsella, A. Muzi, E. Mazzon, M. Vergati, O. Forini, R. Lapidus, W. Xu, A. S. Dorio, et al. Inhibition of poly(ADP-ribose) polymerase prevents irinotecan-induced intestinal damage and enhances irinotecan/temozolomide efficacy against colon carcinoma FASEB J, August 1, 2006; 20(10): 1709 - 1711. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Gookin, J. Allen, S. Chiang, L. Duckett, and M. U. Armstrong Local Peroxynitrite Formation Contributes to Early Control of Cryptosporidium parvum Infection Infect. Immun., July 1, 2005; 73(7): 3929 - 3936. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Mollace, C. Muscoli, E. Masini, S. Cuzzocrea, and D. Salvemini Modulation of Prostaglandin Biosynthesis by Nitric Oxide and Nitric Oxide Donors Pharmacol. Rev., June 1, 2005; 57(2): 217 - 252. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. S. A. Patel, S. Cuzzocrea, P. K. Chatterjee, R. Di Paola, L. Sautebin, D. Britti, and C. Thiemermann Reduction of Renal Ischemia-Reperfusion Injury in 5-Lipoxygenase Knockout Mice and by the 5-Lipoxygenase Inhibitor Zileuton Mol. Pharmacol., August 1, 2004; 66(2): 220 - 227. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Lancel, S. Tissier, S. Mordon, X. Marechal, F. Depontieu, A. Scherpereel, C. Chopin, and R. Neviere Peroxynitrite decomposition catalysts prevent myocardial dysfunction and inflammation in endotoxemic rats J. Am. Coll. Cardiol., June 16, 2004; 43(12): 2348 - 2358. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. G. Nielsen and J. P. Crow Peroxynitrite Decreases Rabbit Tissue Factor Activity In Vitro Anesth. Analg., March 1, 2004; 98(3): 668 - 671. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Jozsef, C. Zouki, N. A. Petasis, C. N. Serhan, and J. G. Filep Lipoxin A4 and aspirin-triggered 15-epi-lipoxin A4 inhibit peroxynitrite formation, NF-kappa B and AP-1 activation, and IL-8 gene expression in human leukocytes PNAS, October 1, 2002; 99(20): 13266 - 13271. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |